Gedeon Richter Plc. — China drug registrations and re-registration deadlines
10 certificates in the NMPA overseas-manufactured drug database (境外生产药品库), snapshot 2026-06-28. Earliest re-registration deadline: 2026-10-13.
| Approval number | Product | Certificate expires | Re-registration deadline (Art. 82) |
|---|---|---|---|
| 国药准字HJ20170208 | Vinpocetine Injection 长春西汀注射液 | 2027-04-13 | 2026-10-13 |
| 国药准字HJ20220070 | Drospirenone and Ethinylestradiol Tablets 屈螺酮炔雌醇片 | 2027-08-09 | 2027-02-09 |
| 国药准字HJ20230049 | Desogestrel and Ethinylestradiol Tablets 去氧孕烯炔雌醇片 | 2028-05-11 | 2027-11-11 |
| 国药准字HJ20130595 | PANANGIN 门冬氨酸钾镁片 | 2028-10-29 | 2028-04-29 |
| 国药准字HJ20140053 | Postinor-2 左炔诺孕酮片 | 2028-11-29 | 2028-05-29 |
| 国药准字HJ20130590 | PANANGIN 门冬氨酸钾镁注射液 | 2028-12-24 | 2028-06-24 |
| 国药准字HJ20130774 | Vinpocetine Tablets 长春西汀片 | 2029-02-28 | 2028-08-28 |
| 国药准字HJ20140728 | Levonorgestrel Tablets 左炔诺孕酮片 | 2029-10-21 | 2029-04-21 |
| 国药准字HJ20250109 | Estradiol Transdermal Spray 雌二醇透皮喷雾剂 | 2030-09-08 | 2030-03-08 |
| 国药准字HJ20160170 | Bromocriptin-Richter 甲磺酸溴隐亭片 | 2031-01-06 | 2030-07-06 |
Under the Provisions for Drug Registration (药品注册管理办法) Art. 82, an application to renew an overseas-manufactured drug registration is filed with the Center for Drug Evaluation no later than 6 months before the certificate expires; the filing line column is that arithmetic applied to the expiry cell. Art. 84(1): a certificate with no application by expiry is not re-registered and is cancelled at expiry. Every figure is taken from the public NMPA database as of 2026-06-28, or computed from it. Registration data changes; the NMPA portal governs. This page states no view on whether any of these products' Domestic Responsible Person (境内责任人) arrangements meet NMPA Announcement No. 137 — that cannot be determined from a public entry.